1. Zivadinov, R, Jakimovski, D, Gandhi, S, et al. Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine. Expert Rev Neurother 2016; 16: 777–793. 2016/04/23.
Google Scholar | Crossref | Medline | ISI2. Cappelle, S, Pareto, D, Tintoré, M, et al. A validation study of manual atrophy measures in patients with multiple sclerosis. Neuroradiology 2020; 62: 955–964.
Google Scholar | Crossref | Medline3. Fujimori, J, Fujihara, K, Wattjes, M, et al. Patterns of cortical grey matter thickness reduction in multiple sclerosis. Brain Behav 2021; 11: e02050. 2021/01/29.
Google Scholar | Crossref | Medline4. Sastre-Garriga, J, Pareto, D, Battaglini, M, et al. MAGNIMS Consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nat Rev Neurol 2020; 16: 171–182.
Google Scholar | Crossref | Medline5. Pontillo, G, Cocozza, S, Di Stasi, M, et al. 2D Linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis. Eur Radiol 2020; 30: 3813–3822.
Google Scholar | Crossref | Medline6. Bermel, RA, Bakshi, R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006; 5: 158–170. 2006/01/24.
Google Scholar | Crossref | Medline | ISI7. Simon, JH, Jacobs, LD, Campion, MK, et al. A longitudinal study of brain atrophy in relapsing multiple sclerosis. The multiple sclerosis collaborative research group (MSCRG). Neurology 1999; 53: 139–148. 1999/07/17.
Google Scholar | Crossref | Medline | ISI8. Bermel, RA, Bakshi, R, Tjoa, C, et al. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol 2002; 59: 275–280. 2002/02/15.
Google Scholar | Crossref | Medline9. Sharma, J, Sanfilipo, MP, Benedict, RH, et al. Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation. AJNR Am J Neuroradiol 2004; 25: 985–996. 2004/06/19.
Google Scholar | Medline10. Thompson, AJ, Banwell, BL, Barkhof, F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17: 162–173. 2017/12/26.
Google Scholar | Crossref | Medline | ISI11. Sato, DK, Callegaro, D, Lana-Peixoto, MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014; 82: 474–481. 2014/01/15.
Google Scholar | Crossref | Medline | ISI12. Takahashi, T, Fujihara, K, Nakashima, I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain, J Neurol 2007; 130: 1235–1243. 2007/04/24.
Google Scholar | Crossref | Medline | ISI13. Kurtzke, JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452. 1983/11/01.
Google Scholar | Crossref | Medline | ISI14. Roxburgh, RH, Seaman, SR, Masterman, T, et al. Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144–1151. 2005/04/13.
Google Scholar | Crossref | Medline | ISI15. Rao, SM, Losinski, G, Mourany, L, et al. Processing speed test: validation of a self-administered, iPad(®)-based tool for screening cognitive dysfunction in a clinic setting. Mult Scler 2017; 23: 1929–1937. 2017/01/13.
Google Scholar | SAGE Journals | ISI16. Kalb, R, Beier, M, Benedict, RH, et al. Recommendations for cognitive screening and management in multiple sclerosis care. Mult Scler 2018; 24: 1665–1680. 2018/10/12.
Google Scholar | SAGE Journals | ISI17. Fujimori, J, Fujihara, K, Ogawa, R, et al. Patterns of regional brain volume loss in multiple sclerosis: a cluster analysis. J Neurol 2020; 267: 395–405. 2019/10/28.
Google Scholar | Crossref | Medline18. Figueira, FF, Santos, VS, Figueira, GM, et al. Corpus callosum index: a practical method for long-term follow-up in multiple sclerosis. Arq Neuropsiquiatr 2007; 65: 931–935. 2007/12/21.
Google Scholar | Crossref | Medline19. Fujimori, J, Uryu, K, Fujihara, K, et al. Measurements of the corpus callosum index and fractional anisotropy of the corpus callosum and their cutoff values are useful to assess global brain volume loss in multiple sclerosis. Mult Scler Relat Disord 2020; 45: 102388. 2020/07/14.
Google Scholar | Crossref | Medline20. Goncalves, LI, Dos Passos, GR, Conzatti, LP, et al. Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosis. Mult Scler Relat Disord 2018; 20: 154–158. 2018/02/08.
Google Scholar | Crossref | Medline21. Granberg, T, Bergendal, G, Shams, S, et al. MRI-defined corpus callosal atrophy in multiple sclerosis: a comparison of volumetric measurements, corpus callosum area and index. J Neuroimaging 2015; 25: 996–1001. 2015/03/20.
Google Scholar | Crossref | Medline22. Azevedo, CJ, Cen, SY, Jaberzadeh, A, et al. Contribution of normal aging to brain atrophy in MS. Neurol Neuroimmunol Neuroinflamm 2019; 6 2020/04/25. DOI: 10.1212/nxi.0000000000000616.
Google Scholar | Crossref | Medline23. Huang, SY, Fan, Q, Machado, N, et al. Corpus callosum axon diameter relates to cognitive impairment in multiple sclerosis. Ann Clin Transl Neurol 2019; 6: 882–892.
Google Scholar | Crossref | Medline24. Manca, R, Stabile, MR, Bevilacqua, F, et al. Cognitive speed and white matter integrity in secondary progressive multiple sclerosis. Mult Scler Relat Disord 2019; 30: 198–207. 2019/02/26.
Google Scholar | Crossref | Medline25. Sormani, MP, Kappos, L, Radue, EW, et al. Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS. Mult Scler 2017; 23: 656–664. 2016/07/15.
Google Scholar | SAGE Journals | ISI26. De Stefano, N, Airas, L, Grigoriadis, N, et al. Clinical relevance of brain volume measures in multiple sclerosis. CNS Drugs 2014; 28: 147–156. 2014/01/22.
Google Scholar | Crossref | Medline | ISI27. Piccolo, L, Kumar, G, Nakashima, I, et al. Multiple sclerosis in Japan appears to be a milder disease compared to the UK. J Neurol 2015; 262: 831–836. 2015/01/22.
Google Scholar | Crossref | Medline28. Akaishi, T, Nakashima, I, Mugikura, S, et al. Whole brain and grey matter volume of Japanese patients with multiple sclerosis. J Neuroimmunol 2017; 306: 68–75. 2017/04/08.
Google Scholar | Crossref | Medline29. Polman, CH, Reingold, SC, Banwell, B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292–302. 2011/03/10.
Google Scholar | Crossref | Medline | ISI